Vanadium compounds have been suggested for treatment of type 2 diabetes.
Oxidovanadium(IV) complex of 1,2-dimethyl-3-hydroxy-4-pyridinonato(dmpp) has been studied.
VO(dmpp)2, has shown antidiabetic properties by in vitro and in vivo studies.
Here we show it also improves glucose-induced insulin secretion in GK pancreatic islets.
This promising result corroborates the use of VO(dmpp)2 for treatment of type 2 diabetes.